Pharmaceutical Industry News and Market Updates
Amgen lung cancer combo shows survival gain in late-stage trial
Late-stage trial results suggest Amgen may strengthen Imdelltra's commercial prospects in small cell lung cancer by pairing it with AstraZeneca's Imfinzi. The study shows the combination cuts the ...
Biotech stocks rally as drug innovation and deal activity lift sector
Biotechnology shares are gaining momentum as clinical progress, takeover activity and new drug platforms revive investor interest across the sector. The rebound is extending from large-cap names ...
Johnson & Johnson reports early-stage prostate cancer drug trial response
Johnson & Johnson says its experimental once-daily oral prostate cancer treatment shows tumor shrinkage or disappearance in an early-stage study of patients with advanced disease. The candidate, ...
Torrent Pharmaceuticals quarterly profit declines as R&D costs offset India sales growth
India's chronic therapy market continues to support strong prescription demand, but higher investment spending is pressuring earnings for some drugmakers. Torrent Pharmaceuticals says ...
India expands cancer drug price cap after court scrutiny of mark-ups
India is moving to cut the cost of 137 cancer medicines from next month after supreme court scrutiny intensified pressure on the government to address steep mark-ups in the treatment chain. The ...
Heineken flags GLP-1 drugs as risk to UK beer sales
Rising use of weight-loss drugs is prompting changes in how British pubs and bars are being advised to serve drinkers. Heineken is warning hospitality venues that shifting consumer behaviour could ...
China drug trials draw western pharma interest amid ethics scrutiny
China is emerging as a faster venue for human testing of new medicines, drawing attention from western drugmakers seeking access to fresh markets and novel treatment approaches. The accelerated ...
Cipla wins court ruling forcing South Africa to redo HIV pill tender awards
South Africa's health department must recalculate and reaward key portions of a R15.5 billion antiretroviral tender after a court found irregularities in the procurement process. The ruling ...
Emzor shifts leadership ahead of API plant launch in Nigeria
Emzor Pharmaceutical Industries is changing its top management structure as it moves closer to opening a new active pharmaceutical ingredient, or API, plant in Nigeria. The handover places ...
Moderna and Merck melanoma vaccine combo cuts recurrence or death risk in Phase 3 trial
Detailed Phase 3 results show the personalized mRNA cancer vaccine developed by Moderna and Merck improves outcomes for melanoma patients when used with Keytruda after surgery. The findings, based ...
Moderna shares slide after leaked cancer vaccine trial data
Moderna shares come under pressure after partial data on its closely watched cancer vaccine reaches the market before the full release. The later disclosure still appears to meet Wall Street ...
UNICEF, Gavi cut Mosquirix vaccine price for malaria programs
Global efforts to expand malaria immunization are set to lower procurement costs after UNICEF and Gavi agreed to reduce the price of the Mosquirix vaccine by about 40%. The change is expected to ...
U.S. lawmakers propose faster clinical trials for rare disease treatments
Lawmakers are moving to reshape how rare disease therapies are tested as regulators and patient groups push for quicker, less costly drug development. The bipartisan proposal would back reusable ...
Cali Fund draws limited biodiversity payments as pharma faces scrutiny
More than 18 months after its launch, a global biodiversity fund designed to channel corporate profits into conservation remains largely unfunded despite its central role in nature finance talks. ...
Arizona supplements seller sentenced, company ordered to forfeit $1.8 million and shut down
Federal authorities are intensifying enforcement against unapproved performance-enhancing substances sold into the U.S. market. In Arizona, Jeffrey McIndoo and his business SARMS Pharm are ...
